Table 1.
Overall Characteristics of Prostate Cancer Survivors, 1975–2014.
| Characteristic | Receiving radiation | Non or Unknown Receiving radiation | P-value |
|---|---|---|---|
| (N = 149,065) | (N = 251,178) | ||
| Age(year) | <.001 | ||
| <60 | 23,685 (15.9%) | 61,212 (24.4%) | |
| 60-74 | 95,086 (63.8%) | 140,575 (56.0%) | |
| >74 | 30,294 (20.3%) | 49,391 (19.7%) | |
| Stage | <.001 | ||
| Localized/regional | 106,422 (71.4%) | 163,048 (64.9%) | |
| Distant | 931 (.6%) | 2786 (1.1%) | |
| Unknown | 41,712 (28.0%) | 85,344 (34.0%) | |
| Year of diagnosis | <.001 | ||
| 1975–1984 | 10,058 (6.7%) | 21,990 (8.8%) | |
| 1985–1994 | 30,372 (20.4%) | 58,497 (23.3%) | |
| 1995–2004 | 56,581 (38.0%) | 82,143 (32.7%) | |
| 2005–2014 | 52,054 (34.9%) | 88,548 (35.3%) | |
| Radiation recode | NA | ||
| ERBT | 103,406 (69.37%) | 0 (0%) | |
| ERBT + BT | 18,834 (12.63%) | 0 (0%) | |
| BT | 26,825 (18%) | 0 (0%) | |
| Survival month | <.001 | ||
| Mean (SD) | 115 (74.8) | 105 (82.2) | |
| Median | 108 | 89 | |
| Developed BC | 3191 (1.9%) | 3234 (.69%) | <.001 |
| Latency(month) | |||
| Mean (SD) | 167 (58.9) | 178 (65.8) | |
| Median | 158 | 172 | |
| Developed RC | 701 (.42%) | 700 (.15%) | |
| Latency(month) | <.001 | ||
| Mean (SD) | 170 (57.9) | 179 (68.4) | |
| Median | 162 | 170 |
BRT: External beam radiotherapy; EBRT+BT: interstitial brachytherapy or a combination of external beam radiotherapy; BT: brachytherapy; SD standard deviation; BC: bladder cancer; RC: rectal cancer.